Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI (CompleteNSTEMI)

January 15, 2025 updated by: Leipzig Heart Science gGmbH

Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI (-COMPLETE-NSTEMI-)

Prospective, randomized, controlled, multicenter, open-label trial to study whether multivessel percutaneous coronary intervention (PCI) is superior over culprit-lesion only PCI in patients with non-ST-segment elevation myocardial infarction (NSTEMI) and multivessel coronary artery disease.

Study Overview

Detailed Description

The complete revascularization versus culprit lesion only PCI in NSTEMI (COMPLETE-NSTEMI) trial aims to investigate whether multivessel complete PCI is superior over culprit-lesion only PCI in patients with NSTEMI and multivessel coronary artery disease.

Study Type

Interventional

Enrollment (Estimated)

3390

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Graz, Austria, 8036
        • Not yet recruiting
        • LKH Univ. Klinikum Graz, Clinical Department of Cardiology
        • Contact:
          • Gabor Thoth-Gayor, MD
      • Innsbruck, Austria, 6020
        • Not yet recruiting
        • Medizinische Universität Innsbruck, Universitätsklinik für Innere Medizin III
        • Contact:
          • Sebastian Reinstadler, MD
      • Wien, Austria, 1160
        • Not yet recruiting
        • Klinik Ottakring, 3. medizinische Abteilung
        • Contact:
          • Alexander Geppert, MD
      • Bad Berka, Germany, 99437
        • Recruiting
        • Zentralklinik Bad Berka, Klinik für Kardiologie
        • Contact:
          • Philipp Lauten, MD
      • Bad Krozingen, Germany, 79189
        • Not yet recruiting
        • Universitäts-Herzzentrum Bad Krozingen, Klinik für Kardiologie und Angiologie
        • Contact:
          • Miroslaw Ferenc, MD
      • Bad Nauheim, Germany, 61231
        • Recruiting
        • Kerckhoff Klinik
        • Contact:
          • Maren Weferling, MD
      • Bad Oeynhausen, Germany, 32545
        • Recruiting
        • Herz- und Diabeteszentrum NRW, Universitätsklinikum der Ruhr-Universität Bochum, Klinik für Allgemeine und Interventionelle Kardiologie/Angiologie
        • Contact:
          • Regine Brinkmann, MD
      • Berlin, Germany, 13353
        • Not yet recruiting
        • Charité - University Medicine Berlin, Department of Internal Medicine and Cardiology, Campus Virchow Klinikum
        • Contact:
          • Tobias Trippel, MD
      • Berlin, Germany, 12683
        • Recruiting
        • BG Klinikum Unfallkrankenhaus Berlin gGmbH, Klinik für Innere Medizin/Kardiologie
        • Contact:
          • Sebastian Winkler, MD
      • Bielefeld, Germany, 33604
        • Recruiting
        • Klinikum Bielefeld gem. GmbH, Klinik für Kardiologie und Internistische Intensivmedizin
        • Contact:
          • Christoph Stellbrink, MD
      • Bochum, Germany, 44791
        • Not yet recruiting
        • Klinik für Kardiologie und Rhythmologie, St. Josef Hospital, Universitätsklinikmum der Ruhr-Universität Bochum
        • Contact:
          • Arash Haghikia, MD
      • Bremen, Germany, 28277
        • Recruiting
        • Klinikum Links der Weser, Innere Medizin II
        • Contact:
          • Harm Wienbergen, MD
      • Dessau, Germany, 06847
        • Not yet recruiting
        • Städtisches Klinikum Dessau; Klinik für Innere Medizin II (Kardiologie, Angiologie, Diabetologie, internistische Intensivmedizin)
        • Contact:
          • Georg Fürnau, MD
      • Dortmund, Germany, 44137
        • Recruiting
        • St. Johannes Hospital, Klinik für Innere Medizin I
        • Contact:
          • Helge Möllmann, MD
      • Dresden, Germany, 01307
        • Recruiting
        • Herzzentrum Dresden GmbH, Universitätsklinik an der Technischen Universität Dresden, Klinik für Innere Medizin und Kardiologie
        • Contact:
          • Axel Linke, MD
      • Düsseldorf, Germany, 40225
        • Recruiting
        • Heinrich Heine Universitätsklinikum Düsseldorf Institut für Kardiologie, Pneumologie und Angiologie
        • Contact:
          • Christian Jung, MD
      • Erfurt, Germany, 99089
        • Recruiting
        • HELIOS Klinikum Erfurt, Medizinische Klinik III - Kardiologie
        • Contact:
          • Alexander Lauten, MD
      • Erlangen, Germany, 91054
        • Recruiting
        • Universitätsklinikum Erlangen, Medizinische Klinik 2
        • Contact:
          • Stephan Achenbach, MD
      • Essen, Germany, 45138
        • Recruiting
        • Elisabeth Krankenhaus Essen, Klinik für Kardiologie und Angiologie
        • Contact:
          • Thomas Schmitz, MD
      • Essen, Germany, 45147
        • Recruiting
        • Universitätsklinikum Essen, Klinik für Kardiologie und Angiologie
        • Contact:
          • Tienush Rassaf, MD
      • Freiburg, Germany, 79106
        • Not yet recruiting
        • Universitätsklinikum Freiburg, Klinik für Kardiologie und Angiologie
        • Contact:
          • Christoph Oliver, MD
      • Fulda, Germany, 36043
        • Recruiting
        • Klinikum Fulda, Medizinischen Klinik 1 - Kardiologie, Angiologie und Intensivmedizin
        • Contact:
          • Volker Schächinger, MD
      • Gießen, Germany, 35392
        • Recruiting
        • Universitätsklinikum Gießen und Marburg GmbH, Medizinische Klinik I, Kardiologie
        • Contact:
          • Samuel Sossalla, MD
      • Greifswald, Germany, 17475
        • Not yet recruiting
        • Universitätsmedizin Greifswald, Klinik und Poliklinik für Innere Medizin B
        • Contact:
          • Marcus Dörr, MD
      • Göttingen, Germany, 37075
        • Not yet recruiting
        • University Medical Center Göttingen, Department of Cardiology and Pneumology, Georg-August University
        • Contact:
          • Karl Toischer, MD, Prof.
      • Halle Saale, Germany, 06120
        • Recruiting
        • Universitätsklinikum Halle (Saale), Klinik für Innere Medizin III
        • Contact:
          • Daniel Sedding, MD
      • Hamburg, Germany, 22763
        • Recruiting
        • Asklepios Klinik Altona
        • Contact:
          • Felix Meincke, MD
      • Hamburg, Germany, 20099
        • Recruiting
        • Asklepios Klinik St. Georg, Kardiologie und Internistische Intensivmedizin
        • Contact:
          • Eike Tigges, MD
      • Hamburg, Germany, 20246
        • Recruiting
        • Universitäres Herz- und Gefäßzentrum UKE Hamburg GmbH, Klinik für Kardiologie
        • Contact:
          • Peter Clemmensen, MD
      • Heidelberg, Germany, 69120
        • Recruiting
        • Klinik für Kardiologie, Angiologie und Pneumologie, Medizinische Klinik 3, Universitätsklinikum Heidelberg
        • Contact:
          • Haitham Abu Sharar, MD
      • Homburg, Germany, 66421
        • Not yet recruiting
        • Universitätsklinikum des Saarlandes, Klinik für Innere Medizin II
        • Contact:
          • Saarraangan Kulenthiran, MD
      • Jena, Germany, 07747
        • Recruiting
        • Universitätsklinikum Jena, Klinik für Innere Medizin I, Kardiologie, Angiologie, Internistische Intensivmedizin
        • Contact:
          • Christian Schulze, MD
      • Karlsruhe, Germany, 76137
        • Recruiting
        • Vincentius-Diakonissen-Kliniken gAG Medizinische Klinik III, Kardiologie, Intensivmedizin, Angiologie
        • Contact:
          • Claudius Jacobshagen, MD
      • Kiel, Germany, 24105
        • Not yet recruiting
        • Universitätsklinikum Schleswig-Holstein, Campus Kiel, Klinik für Innere Medizin III mit den Schwerpunkten Kardiologie und internistische Intensivmedizin
        • Contact:
          • Derk Frank, MD
      • Langen, Germany, 63225
        • Recruiting
        • Asklepios Klinik Langen, Abteilung Medizinische Klinik I
        • Contact:
          • Ralf Lehmann, MD
      • Leipzig, Germany, 04289
        • Recruiting
        • Heart Center Leipzig at University of Leipzig, Department of Internal Medicine/Cardiology
        • Contact:
        • Sub-Investigator:
          • Hans-Josef Feistritzer, MD; PhD; Assoc. Prof
        • Sub-Investigator:
          • Alexander Jobs, MD; PhD; Assoc. Prof
      • Leipzig, Germany, 04103
        • Recruiting
        • Universitätsklinikum Leipzig, Klinik und Poliklinik für Kardiologie
        • Contact:
          • Christian Spies, MD
      • Leipzig, Germany, 04229
        • Not yet recruiting
        • Klinikum St. Georg gGmbH Klinik für Kardiologie und Internistische Intensivmedizin
        • Contact:
          • Norbert Klein, MD
      • Ludwigshafen, Germany, 67063
        • Recruiting
        • Klinikum der Stadt Ludwigshafen, Medizinische B Klinik
        • Contact:
          • Ralf Zahn, MD
      • Lübeck, Germany, 23538
        • Not yet recruiting
        • Universitätsklinikum Schleswig Holstein, Medizinische Klinik II, Campus Lübeck
        • Contact:
          • Ingo Eitel, MD
      • Magdeburg, Germany, 39120
        • Not yet recruiting
        • Universitätsklinikum Magdeburg, Klinik für Kardiologie und Angiologie
        • Contact:
          • Alexander Schmeisser, MD
      • Mannheim, Germany, 68165
        • Not yet recruiting
        • Brüderklinikum Julia Lanz, Theresienkrankenhaus
        • Contact:
          • Ramon Tschierschke, MD
      • Mannheim, Germany, 68167
        • Recruiting
        • Universitätsmedizin Mannheim, I. Medizinische Klinik, Kardiologie, Angiologie, Hämostaseologie und Internistische Intensivmedizin
        • Contact:
          • Ibrahim Akin, MD
      • Marburg, Germany, 35043
        • Not yet recruiting
        • Universitätsklinikum Gießen und Marburg GmbH - Standort Marburg, Klinik für Innere Medizin - Kardiologie, Angiologie und Intensivmedizin
        • Contact:
          • Georgios Chatzis, MD
      • München, Germany, 80336
        • Recruiting
        • Klinikum der Universität München, Medizinische Klinik und Poliklinik I
        • Contact:
          • Konstaninos Rizas, MD
      • München, Germany, 80636
        • Recruiting
        • Deutsches Herzzentrum München, Klinik für Herz- und Kreislauferkrankungen
        • Contact:
          • Adnan Kastrati, MD
      • Neumarkt, Germany, 92318
        • Not yet recruiting
        • Klinikum Neumarkt
        • Contact:
          • Ulrich Reiser, MD
      • Nürnberg, Germany, 90471
        • Recruiting
        • Klinikum Nürnberg, Medizinische Klinik 8 - Schwerpunkt Kardiologie, Universitätsklinik der Paracelsus Medizinischen Privatuniversität
        • Contact:
          • Fadil Ademaj, MD
      • Oldenburg, Germany, 26133
        • Recruiting
        • Universitätsklinik für Kardiologie am Klinikum Oldenburg
        • Contact:
          • Albrecht Elsässer, MD
      • Plauen, Germany, 08529
        • Not yet recruiting
        • Helios Vogtland-Klinikum Plauen
        • Contact:
          • Christian Bietau, MD
      • Regensburg, Germany, 93053
        • Recruiting
        • Universitatsklinikum Regensburg, Klinik und Poliklinik fur Innere Medizin II
        • Contact:
          • Lars Maier, MD
      • Rostock, Germany, 18057
        • Recruiting
        • Universitätsmedizin Rostock, Zentrum für Innere Medizin, Abteilung für Kardiologie
        • Contact:
          • Alper Öner, MD
      • Schwerin, Germany, 19055
        • Recruiting
        • Helios Kliniken Schwerin, Klinik für Kardiologie und Angiologie
        • Contact:
          • Alexander Staudt, MD
      • Trier, Germany, 54292
        • Recruiting
        • Krankenhaus der Barmherzigen Brüder Trier, Herzzentrum Innere Medizin III - Kardiologie
        • Contact:
          • Nikos Werner, MD
      • Tübingen, Germany, 72076
        • Recruiting
        • Universitätsklinikum Tübingen, Medizinische Klinik, Innere Medizin III, Kardiologie und Angiologie
        • Contact:
          • Tobias Geisler, MD
      • Villingen-Schwenningen, Germany, 78052
        • Recruiting
        • Schwarzwald-Baar Klinikum VS, Studienteam Kardiologie
        • Contact:
          • Sebastian Ewen, MD
      • Wolfenbüttel, Germany, 38302
        • Recruiting
        • Städtisches Klinikum Wolfenbüttel gGmbH, Klinik für Innere Medizin - Kardiologie,
        • Contact:
          • Björn Billmann, MD
      • Wuppertal, Germany, 72117
        • Recruiting
        • Helios Klinikum Wuppertal, Herzkreislaufforschung
        • Contact:
          • Melchior Seyfarth, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • NSTEMI as suggested by high-sensitivity troponin algorithms
  • Multivessel coronary artery disease
  • Identifiable culprit lesion
  • Informed consent

Exclusion Criteria:

  • Age <18 years
  • Cardiogenic shock
  • Sustained ventricular tachycardia (VT) or ventricular fibrillation (VF)
  • Contraindication for coronary revascularization
  • Prior coronary artery bypass graft
  • Indication for coronary artery bypass graft surgery
  • Non-culprit lesion located in the left main coronary artery
  • Co-morbidity with life expectancy less than 6 months
  • Type 2 myocardial infarction
  • Pregnancy and breast feeding period

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: culprit-lesion-only revascularization
Patients will receive optimal medical therapy without further revascularization of non-culprit lesions (neither during index hospitalization nor during follow-up). Angina pectoris will be treated medically as recommended in the chronic coronary syndrome guidelines. Revascularization of non-culprit lesions will only be permitted if at least one bailout criteria is met.
Percutaneous coronary intervention of culprit-lesion
Other Names:
  • Culprit-lesion PCI
Experimental: multivessel complete revascularization
Patients will receive complete revascularization of all angiographically significant non-culprit lesions, either during the index procedure, the index hospitalization, or staged within 45 days after PCI of the culprit lesion.
Percutaneous coronary intervention of culprit-lesion
Other Names:
  • Culprit-lesion PCI
Complete percutaneous coronary intervention of all angiographically significant non-culprit lesions
Other Names:
  • multivessel PCI

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Composite rate of cardiovascular death or rehospitalization for non-fatal myocardial infarction
Time Frame: During follow-up (2 years estimated average duration)
During follow-up (2 years estimated average duration)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of Cardiovascular death
Time Frame: During follow-up (2 years estimated average duration)
During follow-up (2 years estimated average duration)
Rate of Rehospitalization for non-fatal myocardial infarction
Time Frame: During follow-up (2 years estimated average duration)
During follow-up (2 years estimated average duration)
Rate of all-cause death
Time Frame: During follow-up (2 years estimated average duration)
During follow-up (2 years estimated average duration)
Rate of ischemia-driven revascularization
Time Frame: During follow-up (2 years estimated average duration)
During follow-up (2 years estimated average duration)
Rate of rehospitalization for heart failure
Time Frame: During follow-up (2 years estimated average duration)
During follow-up (2 years estimated average duration)
Composite rate of all-cause death, rehospitalization for non-fatal myocardial infarction, or rehospitalization for ischemia-driven revascularization
Time Frame: During follow-up (2 years estimated average duration)
During follow-up (2 years estimated average duration)
Rate of coronary artery bypass surgery
Time Frame: During follow-up (2 years estimated average duration)
During follow-up (2 years estimated average duration)
Quality of Life (EQ-5D-5L)
Time Frame: 12 months
European Quality of Life 5 Dimensions 5 Level (EQ-5D-5L) Score 1-5 for each dimension, 1 means best outcome EQ VAS score between 0 and 100; higher score means better outcome
12 months
Rate of bleeding
Time Frame: 6 months
6 months
Rate of stroke
Time Frame: 6 months
Ischemic and Hemorrhagic
6 months
Rate of contrast-induced acute kidney injury
Time Frame: 6 months
AKIN grade I-III
6 months
Rate of coronary procedure-related myocardial infarction
Time Frame: 6 months
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Holger Thiele, MD, Prof. Dr., Heart Center Leipzig at University of Leipzig, Department of Internal Medicine/Cardiology

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 27, 2023

Primary Completion (Estimated)

January 31, 2027

Study Completion (Estimated)

July 31, 2027

Study Registration Dates

First Submitted

March 14, 2023

First Submitted That Met QC Criteria

March 14, 2023

First Posted (Actual)

March 27, 2023

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 15, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Multivessel Coronary Artery Disease

Clinical Trials on Culprit-lesion revascularization

Subscribe